Valsasina Paola, Rocca Maria A, Horsfield Mark A, Copetti Massimiliano, Filippi Massimo
Neuroimaging Research Unit, Institute of Experimental Neurology, Division of Neuroscience, San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Via Olgettina, 60, 20132, Milan, Italy.
J Neurol. 2015 Jul;262(7):1622-8. doi: 10.1007/s00415-015-7754-z. Epub 2015 May 1.
There is an urgent need of fast and accurate methods for the longitudinal quantification of cervical cord atrophy in multiple sclerosis (MS). Aim of this study was to compare a new semi-automatic method [the active surface (AS) method] with an existing cord segmentation method (the Losseff method) to measure cervical cord atrophy progression in MS patients. Using the AS and Losseff methods, normalized cervical cord cross-sectional area (CSA) was compared between 35 MS patients and 9 healthy controls (HC) at baseline and after 2.3 years of follow-up. Correlations with clinical/conventional MRI variables and a power calculation study were also performed. At follow-up, the Losseff method detected a 1 % CSA increase in HC and a 3.5 % decrease in MS patients (p = 0.01), while the AS method detected a 0.1 % decrease in HC and 3 % decrease in MS patients (p = 0.02). The AS method was more sensitive to associations with disability/conventional MRI variables and also provided lower numbers of subjects per arm compared to the Losseff method in a putative clinical trial scenario. Cord AS CSA measurements were more sensitive to longitudinal changes in MS patients than Losseff measurements. Cord AS CSA might be a valuable surrogate outcome measure for monitoring neuroprotection in MS.
迫切需要快速准确的方法来纵向量化多发性硬化症(MS)患者颈髓萎缩情况。本研究旨在比较一种新的半自动方法[活性表面(AS)法]与现有的脊髓分割方法(Losseff法),以测量MS患者颈髓萎缩的进展。使用AS法和Losseff法,比较了35例MS患者和9名健康对照者(HC)在基线和随访2.3年后的标准化颈髓横截面积(CSA)。还进行了与临床/传统MRI变量的相关性分析以及功效计算研究。随访时,Losseff法检测到HC的CSA增加了1%,MS患者减少了3.5%(p = 0.01),而AS法检测到HC减少了0.1%,MS患者减少了3%(p = 0.02)。在假定的临床试验场景中,AS法对与残疾/传统MRI变量的关联更敏感,并且与Losseff法相比,每组所需的受试者数量更少。与Losseff测量相比,脊髓AS CSA测量对MS患者的纵向变化更敏感。脊髓AS CSA可能是监测MS神经保护的有价值的替代结局指标。